<html>
<head>
    <script language="JavaScript" src="http://code.jquery.com/jquery-1.4.4.js"></script>
    <script language="JavaScript" src="../js/pie.js"></script>
    <script language="JavaScript" src="../js/browser_adjust.js"></script>
    <script language="JavaScript" src="../js/search.js"></script>


    <script type="text/JavaScript">
    <!--

    var array = [[9.4136999047, "../topics/{product,_candidate,_development}.html", "{product,_candidate,_development}"], [7.4582300592, "../topics/{product,_liability,_claim}.html", "{product,_liability,_claim}"], [3.9438381393, "../topics/{product,_market,_service}.html", "{product,_market,_service}"], [3.557598059, "../topics/{acquisition,_growth,_future}.html", "{acquisition,_growth,_future}"], [3.5129632214, "../topics/{regulation,_government,_change}.html", "{regulation,_government,_change}"], [2.6979781361, "../topics/{property,_intellectual,_protect}.html", "{property,_intellectual,_protect}"], [2.6954643149, "../topics/{cost,_regulation,_environmental}.html", "{cost,_regulation,_environmental}"], [2.2663157122, "../topics/{control,_financial,_internal}.html", "{control,_financial,_internal}"], [1.7049369739, "../topics/{customer,_product,_revenue}.html", "{customer,_product,_revenue}"], [1.702707199, "../topics/{operation,_international,_foreign}.html", "{operation,_international,_foreign}"], [1.7024000569, "../topics/{system,_service,_information}.html", "{system,_service,_information}"], [1.6984088415, "../topics/{personnel,_key,_retain}.html", "{personnel,_key,_retain}"], [1.6956601029, "../topics/{regulation,_change,_law}.html", "{regulation,_change,_law}"], [1.6898429596, "../topics/{loan,_real,_estate}.html", "{loan,_real,_estate}"], [1.6874259584, "../topics/{condition,_economic,_financial}.html", "{condition,_economic,_financial}"]];
    var elements = generate_pie_elements(array);
    var piec = null;
    function init() {
        browser_adjust();
        
        // create pie chart
        piec = new PieChart(elements);
        piec.initialize();

    }

    function highlight(i) {
        piec.highlight(i);
    }
    
    function unhighlight() {
        piec.unhighlight();
    }
    //-->
    </script>

    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    
    <title>1131324--3/15/2010--GENOMIC_HEALTH_INC</title>

    <link href="../styling.css" rel="stylesheet" type="text/css">
</head>

<body onLoad="init()">
<div id="navigation">
<hr noshade>
<table><tr>
    <td class="navtext">Browse&nbsp;&#x25B8;</td> 
    <td class="linked"><a>Topics</a>
      <ul> 
        <li><a href="../browse/topic-list.html">List of Terms</a></li> 
        <li><a href="../browse/topic-graph.html">Term Distributions</a></li> 
        <li><a href="../browse/topic-presence.html">Relative Presence</a></li>
      </ul> 
    </td> 
    <td class="linked"><a>Documents</a>
      <ul>
        <li><a href="../browse/doc-graph.html">Topic Distributions</a></li>
      </ul> 
    </td>
    <td class="linked"><a>Terms</a>
      <ul> 
        <li><a href="../browse/term-list.html">List by Frequency</a></li> 
        <li><a href="../browse/term-graph.html">Topic Distributions</a></li> 
       </ul> 
    </td>
    <td class="linked"><a>About</a>
      <ul>
        <li><a href="http://www.cs.princeton.edu/~blei/lda-c/">LDA</a></li>
      </ul> 
    </td>
    
    </td>
    <td></td>
    <td class="searchbar"> Search&nbsp;&#x25B8;</td>
    <td class="searchbar"><input type="text" name="search" size="20" onkeypress="handleKeyPress(event)"><span onclick="doSearch()"></span>
    </td>
</tr></table>
</div>

    <div id="top"></div>

    <h1 id="header">
        <table><tr>
            <td id="title">1131324--3/15/2010--GENOMIC_HEALTH_INC</td>
        </tr></table>

        <hr noshade>
    </h1>

    <div id="main">
        <table><tr>
            <td width="210px">
                <table class="dark">
                <tr><td><canvas id="canvas" width="200" height="200"></canvas></td></tr>
                <tr class="title">
                    <td>related topics</td>
                </tr>
                <tr class="list"><td id="{product,_candidate,_development}" onmouseover="highlight(0)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{product,_candidate,_development}.html'">{product, candidate, development}</td></tr>
<tr class="list"><td id="{product,_liability,_claim}" onmouseover="highlight(1)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{product,_liability,_claim}.html'">{product, liability, claim}</td></tr>
<tr class="list"><td id="{product,_market,_service}" onmouseover="highlight(2)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{product,_market,_service}.html'">{product, market, service}</td></tr>
<tr class="list"><td id="{acquisition,_growth,_future}" onmouseover="highlight(3)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{acquisition,_growth,_future}.html'">{acquisition, growth, future}</td></tr>
<tr class="list"><td id="{regulation,_government,_change}" onmouseover="highlight(4)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{regulation,_government,_change}.html'">{regulation, government, change}</td></tr>
<tr class="list"><td id="{property,_intellectual,_protect}" onmouseover="highlight(5)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{property,_intellectual,_protect}.html'">{property, intellectual, protect}</td></tr>
<tr class="list"><td id="{cost,_regulation,_environmental}" onmouseover="highlight(6)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{cost,_regulation,_environmental}.html'">{cost, regulation, environmental}</td></tr>
<tr class="list"><td id="{control,_financial,_internal}" onmouseover="highlight(7)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{control,_financial,_internal}.html'">{control, financial, internal}</td></tr>
<tr class="list"><td id="{customer,_product,_revenue}" onmouseover="highlight(8)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{customer,_product,_revenue}.html'">{customer, product, revenue}</td></tr>
<tr class="list"><td id="{operation,_international,_foreign}" onmouseover="highlight(9)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{operation,_international,_foreign}.html'">{operation, international, foreign}</td></tr>
<tr class="list"><td id="{system,_service,_information}" onmouseover="highlight(10)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{system,_service,_information}.html'">{system, service, information}</td></tr>
<tr class="list"><td id="{personnel,_key,_retain}" onmouseover="highlight(11)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{personnel,_key,_retain}.html'">{personnel, key, retain}</td></tr>
<tr class="list"><td id="{regulation,_change,_law}" onmouseover="highlight(12)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{regulation,_change,_law}.html'">{regulation, change, law}</td></tr>
<tr class="list"><td id="{loan,_real,_estate}" onmouseover="highlight(13)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{loan,_real,_estate}.html'">{loan, real, estate}</td></tr>
<tr class="list"><td id="{condition,_economic,_financial}" onmouseover="highlight(14)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{condition,_economic,_financial}.html'">{condition, economic, financial}</td></tr>

                </table>
            </td>

            <td>
                <table class="light">
                <tr class="doc"><td>
                    We expect to continue to incur significant expenses to develop and market out tests, which may make it difficult for us to achieve profitability.
Changes in healthcare policy could increase our costs and impact sales of and reimbursement for our tests.
If third-party payors, including managed care organizations and Medicare, do not provide reimbursement, breach, rescind or modify their contracts or reimbursement policies or delay payments for our Oncotype DX tests, our commercial success could be compromised.
The prices at which our tests are reimbursed may be reduced by Medicare and private and other payors, and any such changes could have a negative impact on our revenues.
If we are unable to obtain reimbursement for our tests outside of the U.S., our ability to expand internationally will be compromised.
Because of Medicare billing rules, we may not receive reimbursement for all tests provided to Medicare patients.
We depend on a limited number of payors for a significant portion of our product revenues and if these or other payors stop providing reimbursement or decrease the amount of reimbursement for our tests, our revenues could decline.
Our financial results depend on sales of one test, our Oncotype DX breast cancer test, and we will need to generate sufficient revenues from this and other tests to run our business.
If FDA were to begin regulating our tests, we could incur substantial costs and time delays associated with meeting requirements for pre-market clearance or approval or we could experience decreased demand for or reimbursement of our tests.
If we were required to conduct additional clinical trials prior to continuing to sell our breast and colon cancer tests or any other tests we may develop, those trials could lead to delays or failure to obtain necessary regulatory approval, which could cause significant delays in commercializing any future products and harm our ability to become profitable.
Complying with numerous regulations pertaining to our business is an expensive and time-consuming process, and any failure to comply could result in substantial penalties
Declining general economic or business conditions could have a negative impact on our business.
New test development involves a lengthy and complex process, and we may be unable to commercialize any of the tests we are currently developing.
If we are unable to support demand for our tests, including successfully managing the evolution of our technology and manufacturing platforms, our business could suffer.
We may experience limits on our revenues if physicians decide not to order our tests.
We may experience limits on our revenues if patients decide not to use our tests.
If we are unable to develop products to keep pace with rapid technological, medical and scientific change, our operating results and competitive position could be harmed.
Our rights to use technologies licensed from third parties are not within our control, and we may not be able to sell our products if we lose our existing rights or cannot obtain new rights on reasonable terms.
If we are unable to maintain intellectual property protection, our competitive position could be harmed.
We may face intellectual property infringement claims that could be time-consuming and costly to defend, and could result in our loss of significant rights and the assessment of treble damages.
If we are unable to compete successfully, we may be unable to increase or sustain our revenues or achieve profitability.
Our research and development efforts will be hindered if we are not able to contract with third parties for access to archival tissue samples.
If we cannot maintain our current clinical collaborations and enter into new collaborations, our product development could be delayed.
The loss of key members of our senior management team or our inability to retain highly skilled scientists, clinicians and salespeople could adversely affect our business.
If our sole laboratory facility becomes inoperable, we will be unable to perform our tests and our business will be harmed.
We are dependent on our information technology and telecommunications systems, and any failure of these systems could harm our business.
We rely on a limited number of suppliers or, in some cases, a sole supplier, for some of our laboratory instruments and materials and may not be able to find replacements in the event our suppliers no longer supply that equipment or those materials.
We may be unable to manage our future growth effectively, which could make it difficult to execute our business strategy.
If we were sued for product liability or professional liability, we could face substantial liabilities that exceed our resources.
If we use biological and hazardous materials in a manner that causes injury, we could be liable for damages.
International expansion of our business exposes us to business, regulatory, political, operational, financial and economic risks associated with doing business outside of the U.S.
Our dependence on distributors for foreign sales of our Oncotype DX tests could limit or prevent us from selling our test in foreign markets and from realizing long-term international revenue growth.
We may acquire other businesses or form joint ventures that could harm our operating results, dilute our stockholders ownership, increase our debt or cause us to incur significant expense.
Our marketable securities are subject to risks that could adversely affect our overall financial position.
Our inability to raise additional capital on acceptable terms in the future may limit our ability to develop and commercialize new tests and technologies and expand our operations.
We must implement additional and expensive finance and accounting systems, procedures and controls as we grow our business and organization and to satisfy public company reporting requirements, which will increase our costs and require additional management resources.
We are subject to increasingly complex taxation rules and practices, which may affect how we conduct our business and our results of operations.
<p><a href="http://www.sec.gov/Archives/edgar/data/1131324/0000950123-10-024793.txt">Full 10-K form&nbsp;&#x25B8;</a></p>
                </td></tr>
                </table>
            </td>

            <td width="25%">
                <table class="dark">
                <tr class="title">
                    <td>related documents</td>
                </tr>
                <tr class="list"><td onclick="window.location.href='../docs/792977--2-26-2010--AMAG_PHARMACEUTICALS_INC..html'">792977--2/26/2010--AMAG_PHARMACEUTICALS_INC.</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/827809--3-1-2007--QLT_INC-BC.html'">827809--3/1/2007--QLT_INC/BC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1131324--3-22-2006--GENOMIC_HEALTH_INC.html'">1131324--3/22/2006--GENOMIC_HEALTH_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1131324--3-13-2009--GENOMIC_HEALTH_INC.html'">1131324--3/13/2009--GENOMIC_HEALTH_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1131324--3-14-2008--GENOMIC_HEALTH_INC.html'">1131324--3/14/2008--GENOMIC_HEALTH_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/815838--3-13-2009--NOVEN_PHARMACEUTICALS_INC.html'">815838--3/13/2009--NOVEN_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1012140--2-25-2009--ONYX_PHARMACEUTICALS_INC.html'">1012140--2/25/2009--ONYX_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/737207--3-15-2006--NASTECH_PHARMACEUTICAL_CO_INC.html'">737207--3/15/2006--NASTECH_PHARMACEUTICAL_CO_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1124140--3-31-2009--EXACT_SCIENCES_CORP.html'">1124140--3/31/2009--EXACT_SCIENCES_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1051514--3-12-2008--ELECTRO_OPTICAL_SCIENCES_INC_-NY.html'">1051514--3/12/2008--ELECTRO_OPTICAL_SCIENCES_INC_/NY</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1051514--3-15-2007--ELECTRO_OPTICAL_SCIENCES_INC_-NY.html'">1051514--3/15/2007--ELECTRO_OPTICAL_SCIENCES_INC_/NY</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1012140--2-29-2008--ONYX_PHARMACEUTICALS_INC.html'">1012140--2/29/2008--ONYX_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1093557--2-27-2007--DEXCOM_INC.html'">1093557--2/27/2007--DEXCOM_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/874663--5-21-2010--ALKERMES_INC.html'">874663--5/21/2010--ALKERMES_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/815838--3-15-2006--NOVEN_PHARMACEUTICALS_INC.html'">815838--3/15/2006--NOVEN_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/815838--3-12-2007--NOVEN_PHARMACEUTICALS_INC.html'">815838--3/12/2007--NOVEN_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/356830--2-6-2008--OSCIENT_PHARMACEUTICALS_CORP.html'">356830--2/6/2008--OSCIENT_PHARMACEUTICALS_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1178104--9-19-2007--CARDICA_INC.html'">1178104--9/19/2007--CARDICA_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/815838--4-1-2008--NOVEN_PHARMACEUTICALS_INC.html'">815838--4/1/2008--NOVEN_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1012140--3-16-2006--ONYX_PHARMACEUTICALS_INC.html'">1012140--3/16/2006--ONYX_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/884731--3-14-2007--ARIAD_PHARMACEUTICALS_INC.html'">884731--3/14/2007--ARIAD_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1371217--3-12-2009--EnteroMedics_Inc.html'">1371217--3/12/2009--EnteroMedics_Inc</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1072379--4-15-2008--NORTHWEST_BIOTHERAPEUTICS_INC.html'">1072379--4/15/2008--NORTHWEST_BIOTHERAPEUTICS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1131324--3-16-2007--GENOMIC_HEALTH_INC.html'">1131324--3/16/2007--GENOMIC_HEALTH_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1013238--3-30-2009--ARADIGM_CORP.html'">1013238--3/30/2009--ARADIGM_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1012140--3-5-2007--ONYX_PHARMACEUTICALS_INC.html'">1012140--3/5/2007--ONYX_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/874255--3-15-2006--MEDAREX_INC.html'">874255--3/15/2006--MEDAREX_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/921506--2-28-2008--CV_THERAPEUTICS_INC.html'">921506--2/28/2008--CV_THERAPEUTICS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1098972--3-16-2009--ANTIGENICS_INC_-DE-.html'">1098972--3/16/2009--ANTIGENICS_INC_/DE/</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/944522--3-23-2009--VION_PHARMACEUTICALS_INC.html'">944522--3/23/2009--VION_PHARMACEUTICALS_INC</td></tr>

                </table>
            </td>
        </tr></table>
    </div>

    <div id="footer">
        <br>
        <hr noshade>
    </div>
</body>
</html>
